CHUGAI PHARMACEUTICAL
CHUGAI PHARMACEUTICAL
Share · JP3519400000 · 857216 (LSSI)
Overview
No Price
16.12.2025 07:12
Current Prices from CHUGAI PHARMACEUTICAL
ExchangeTickerCurrencyLast TradePriceDaily Change
XHAM: Hamburg
Hamburg
CPCLRS00.HAMB
EUR
16.12.2025 07:12
45,13 EUR
-1,26 EUR
-2,72 %
XHAN: Hannover
Hannover
CPCLRS00.HANB
EUR
16.12.2025 07:01
44,92 EUR
-1,47 EUR
-3,17 %
XDQU: Quotrix
Quotrix
CPCLRS00.DUSD
EUR
16.12.2025 06:27
45,65 EUR
-0,74 EUR
-1,60 %
XDUS: Düsseldorf
Düsseldorf
CPCLRS00.DUSB
EUR
15.12.2025 18:31
46,28 EUR
0,27 EUR
+0,59 %
XFRA: Frankfurt
Frankfurt
CUP.F
EUR
15.12.2025 14:29
46,39 EUR
0,38 EUR
+0,83 %
XTKS: Tokyo
Tokyo
4519.T
JPY
09.12.2025 05:42
8.230,00 JPY
6,00 JPY
+0,07 %
OTC: UTC
UTC
CHGCF
USD
08.12.2025 21:00
52,45 USD
-1,20 USD
-2,24 %
Share Float & Liquidity
Free Float 38,88 %
Shares Float 639,77 M
Shares Outstanding 1,65 B
Invested Funds

The following funds have invested in CHUGAI PHARMACEUTICAL:

Fund
iShares MSCI Japan SRI UCITS ETF USD (Dist)
Vol. in million
2.158,27
Percentage (%)
2,70 %
Fund
iShares MSCI Japan SRI UCITS ETF
Vol. in million
19.953,67
Percentage (%)
2,70 %
Fund
iShares MSCI Japan SRI EUR Hedged UCITS ETF (Acc)
Vol. in million
1.651,96
Percentage (%)
2,55 %
Fund
iShares Nikkei 225® UCITS ETF (DE)
Vol. in million
360.077,30
Percentage (%)
1,63 %
Fund
iShares Refinitiv Inclusion and Diversity UCITS ETF
Vol. in million
379,76
Percentage (%)
0,97 %
Company Profile for CHUGAI PHARMACEUTICAL Share
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
Get up to date insights from finAgent about CHUGAI PHARMACEUTICAL

Company Data

Name CHUGAI PHARMACEUTICAL
Company Chugai Pharmaceutical Co., Ltd.
Website https://www.chugai-pharm.co.jp
Primary Exchange LSSI Lang & Schwarz
WKN 857216
ISIN JP3519400000
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Osamu Okuda
Market Capitalization 14.094 Mrd.
Country Japan
Currency EUR
Employees 5,0 T
Address Nihonbashi Mitsui Tower, 103-8324 Tokyo
IPO Date 2000-01-04

Ticker Symbols

Name Symbol
Over The Counter CHGCF
Düsseldorf CPCLRS00.DUSB
Frankfurt CUP.F
Hamburg CPCLRS00.HAMB
Hannover CPCLRS00.HANB
Quotrix CPCLRS00.DUSD
Tokyo 4519.T
More Shares
Investors who hold CHUGAI PHARMACEUTICAL also have the following shares in their portfolio:
BARRICK GOLD CORP
BARRICK GOLD CORP Share
ClimateRock - Unit
ClimateRock - Unit Share
CLOROX CO 18/28
CLOROX CO 18/28 Bond
GAZPROM ADR
GAZPROM ADR Share
GENMAB AS            DK 1
GENMAB AS DK 1 Share
HOCHTIEF AG
HOCHTIEF AG Share
LUNDIN ENERGY      SK-,01
LUNDIN ENERGY SK-,01 Share
MEDTRONIC PLC
MEDTRONIC PLC Share
NEMETSCHEK SE
NEMETSCHEK SE Share
PSI SOFTWARE AG
PSI SOFTWARE AG Share
USU SOFTWARE AG
USU SOFTWARE AG Share
XINJIANG GOLDWIND
XINJIANG GOLDWIND Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025